Trial Profile
Clinical study of combination local injection sclerotherapy of bleomycin and OK-432 for intractable lymphatic malformations
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Aug 2019
Price :
$35
*
At a glance
- Drugs Picibanil (Primary) ; Bleomycin
- Indications Lymphangioma; Lymphatic disorders
- Focus Therapeutic Use
- 04 Aug 2019 Status changed from recruiting to active, no longer recruiting.
- 17 Sep 2016 Status changed from not yet recruiting to recruiting.
- 12 Aug 2016 New trial record